CAH Newborn Screening in India: Challenges and Opportunities

CAH Newborn Screening in India: Challenges and Opportunities

Congenital adrenal hyperplasia (CAH) is a common treatable disorder which is associated with life-threatening adrenal crisis, sexual ambiguity, and/or abnormal growth if undiagnosed. Newborn screening is a cost-effective tool to detect affected babies early after birth to optimize their treatment an...

Full description

Bibliographic Details
Main Authors:	Aashima Dabas, Meenakshi Bothra, Seema Kapoor
Format:	Article
Language:	English
Published:	MDPI AG 2020-08-01
Series:	International Journal of Neonatal Screening
Subjects:	newborn screening congenital adrenal hyperplasia CAH
Online Access:	https://www.mdpi.com/2409-515X/6/3/70

Similar Items

Impact of Newborn Screening on Clinical Presentation of Congenital Adrenal Hyperplasia
by: Rūta Navardauskaitė, et al.
Published: (2021-09-01)

Newborn Screening in Pediatric Endocrine Disorders
by: Martin Draznin, et al.
Published: (2022-03-01)

Devastating salt‐wasting crisis in a four‐month‐old male child with congenital adrenal hyperplasia, highlighting the essence of neonatal screening
by: Nagaspurthy Anugu Reddy, et al.
Published: (2022-07-01)

Thirty-Year Lessons from the Newborn Screening for Congenital Adrenal Hyperplasia (CAH) in Japan
by: Atsumi Tsuji-Hosokawa, et al.
Published: (2021-06-01)

Prevalence of CAH-X Syndrome in Italian Patients with Congenital Adrenal Hyperplasia (CAH) Due to 21-Hydroxylase Deficiency
by: Rosa Maria Paragliola, et al.
Published: (2022-07-01)

Should CAH in females be classified as DSD?
by: Ricardo eGonzález, et al.
Published: (2016-05-01)

Pregnanetriolone in paper-borne urine for neonatal screening for 21-hydroxylase deficiency: The place of urine in neonatal screening
by: José Ramón Alonso-Fernández
Published: (2016-09-01)

Newborn Screening for Congenital Adrenal Hyperplasia: Review of Factors Affecting Screening Accuracy
by: Patrice K. Held, et al.
Published: (2020-08-01)

Evaluation of a New Laboratory Protocol for Newborn Screening for Congenital Adrenal Hyperplasia in New Zealand
by: Mark R. de Hora, et al.
Published: (2022-10-01)

Measurement of 17-Hydroxyprogesterone by LCMSMS Improves Newborn Screening for CAH Due to 21-Hydroxylase Deficiency in New Zealand
by: Mark R de Hora, et al.
Published: (2020-01-01)

Pseudogene <i>TNXA</i> Variants May Interfere with the Genetic Testing of CAH-X
by: Qizong Lao, et al.
Published: (2023-01-01)

Newborn Screening Protocols and Positive Predictive Value for Congenital Adrenal Hyperplasia Vary across the United States
by: Phyllis W. Speiser, et al.
Published: (2020-05-01)

Landscape of Congenital Adrenal Hyperplasia Newborn Screening in the United States
by: Sari Edelman, et al.
Published: (2020-08-01)

The use of liquid chromatography-tandem mass spectrometry in newborn screening for congenital adrenal hyperplasia: improvements and future perspectives
by: Mark de Hora, et al.
Published: (2023-10-01)

An Insight into Indonesia’s Challenges in Implementing Newborn Screening Programs and Their Future Implications
by: Gilbert Sterling Octavius, et al.
Published: (2023-07-01)

Molecular Analysis of a Family With Congenital Adrenal Hyperplasia - Genotype/Phenotype Discrepancy
by: Anastasovska V, et al.
Published: (2007-01-01)

The Relative Prevalence of Testicular Adrenal Rest Tumors in Fewer than 20-Years-Old Boys with Congenital Adrenal Hyperplasia
by: Mohammad Hassan Moadab, et al.
Published: (2014-09-01)

Course of COVID-19 infection in patients with congenital adrenal hyperplasia
by: Rida Javaid, et al.
Published: (2024-02-01)

Is It Beneficial to Patients to Include Congenital Adrenal Hyperplasia (CAH) Among the Disorders of Sex Development (DSD)?
by: Ricardo González, et al.
Published: (2018-11-01)

25 Years of Newborn Screening in Uruguay
by: Cecilia Queijo, et al.
Published: (2021-06-01)

The Success of a Screening Program Is Largely Dependent on Close Collaboration between the Laboratory and the Clinical Follow-Up of the Patients
by: Svetlana Lajic, et al.
Published: (2020-08-01)

Reproductive Function and Fertility in Women with Congenital Adrenal Hyperplasia
by: Nigel Pereira, et al.
Published: (2018-08-01)

Molecular characterization of the new clinical entity associated with congenital adrenal hyperplasia: the CAH-X syndrome in the Spanish population
by: Figueras Laura Martínez, et al.
Published: (2023-08-01)

A TNXB splice donor site variant as a cause of hypermobility type Ehlers–Danlos syndrome in patients with congenital adrenal hyperplasia
by: Qizong Lao, et al.
Published: (2021-02-01)

Clinicoradiologic diagnosis of a rare type of congenital adrenal hyperplasia: A case report from Nepal
by: Hensan Khadka, et al.
Published: (2022-06-01)

Newborn screening for congenital adrenal hyperplasia in New York State
by: Melissa Pearce, et al.
Published: (2016-06-01)

Testicular Adrenal Rest Tumors (TARTS) With Unusual Histological Features in Congenital Adrenal Hyperplasia (CAH)
by: Valeri Marianovsky, et al.
Published: (2015-07-01)

FAMILY EDUCATION STRATEGIES IN CARING FOR CHILDREN WITH CONGENITAL ADRENAL HYPERPLASIA (CAH): A LITERATURE REVIEW
by: Meira Erawati, et al.
Published: (2020-12-01)

Update on the Swedish Newborn Screening for Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency
by: Rolf H. Zetterström, et al.
Published: (2020-08-01)

Newborn screening for congenital hypothyroidism, congenital adrenal hyperplasia and glucose-6-phosphate dehydrogenase deficiency in Bihar: A pressing priority in today's time
by: Bandana Kumari, et al.
Published: (2023-01-01)

Cardiometabolic Health in Adolescents and Young Adults with Congenital Adrenal Hyperplasia
by: Ruta Navardauskaite, et al.
Published: (2022-03-01)

Clinical Update on Congenital Adrenal Hyperplasia: Recommendations from a Multidisciplinary Adrenal Program
by: Thomas Uslar, et al.
Published: (2023-04-01)

The Cost-Effectiveness of Congenital Adrenal Hyperplasia Newborn Screening in Brazil: A Comparison Between Screened and Unscreened Cohorts
by: Mirela Costa de Miranda, et al.
Published: (2021-05-01)

Neonatal Screening for Congenital Adrenal Hyperplasia in Turkey: A Pilot Study with 38,935 Infants
by: Tülay Güran, et al.
Published: (2019-03-01)

Children with premature pubarche: is an alterated neonatal 17-Ohp screening test a predictive factor?
by: Paolo Cavarzere, et al.
Published: (2018-01-01)

Wisconsin’s Screening Algorithm for the Identification of Newborns with Congenital Adrenal Hyperplasia
by: Eric R. Bialk, et al.
Published: (2019-09-01)

Differences in Hyperandrogenism Related to Early Detection of Non-Classical Congenital Adrenal Hyperplasia on Second Newborn Screen
by: Bonnie McCann-Crosby, et al.
Published: (2023-09-01)

A Simple Method Adopted for Tooth Sectioning in Dr. Ishratul- Ebad Khan Institute of Oral Health Sciences, DUHS
by: Amynah Charania, et al.
Published: (2010-08-01)

A Simple Method Adopted for Tooth Sectioning in Dr. Ishratul- Ebad Khan Institute of Oral Health Sciences, DUHS
by: Amynah Charania, et al.
Published: (2010-08-01)

The Application of Principal Component Analysis on Clinical and Biochemical Parameters Exemplified in Children With Congenital Adrenal Hyperplasia
by: Marie Lindhardt Ljubicic, et al.
Published: (2021-08-01)